Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
21
HRTX Quote, Financials, Valuation and Earnings
Last price:
$2.01
Seasonality move
:
-11.19%
Day range:
$2.00 - $2.05
52-week range:
$1.04 - $3.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.06x
P/B ratio:
--
Volume:
861.3K
Avg. volume:
1.4M
1-year change:
-42.86%
Market cap:
$305.1M
Revenue:
$144.3M
EPS (TTM):
-$0.05
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $88.6M | $86.3M | $107.7M | $127M | $144.3M | |
| Revenue Growth (YoY) | -39.28% | -2.59% | 24.7% | 17.99% | 13.57% | |
| Cost of Revenues | $36.2M | $46M | $54.9M | $65.1M | $38.6M | |
| Gross Profit | $52.4M | $40.3M | $52.8M | $61.9M | $105.6M | |
| Gross Profit Margin | 59.17% | 46.7% | 49.04% | 48.75% | 73.21% | |
| R&D Expenses | $174.5M | $130.8M | $82.7M | $39.1M | $16.7M | |
| Selling, General & Admin | $106.1M | $127.3M | $144.8M | $133.4M | $100.5M | |
| Other Inc / (Exp) | -$847K | -$878K | -$6.5M | $560K | $430K | |
| Operating Expenses | $280.6M | $258.2M | $227.5M | $172.6M | $117.2M | |
| Operating Income | -$228.2M | -$217.8M | -$174.7M | -$110.6M | -$11.5M | |
| Net Interest Expenses | -- | $2M | $836K | $504K | $2.5M | |
| EBT. Incl. Unusual Items | -$227.3M | -$220.7M | -$182M | -$110.6M | -$13.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$227.3M | -$220.7M | -$182M | -$110.6M | -$13.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$227.3M | -$220.7M | -$182M | -$110.6M | -$13.6M | |
| Basic EPS (Cont. Ops) | -$2.50 | -$2.24 | -$1.67 | -$0.80 | -$0.09 | |
| Diluted EPS (Cont. Ops) | -$2.50 | -$2.24 | -$1.67 | -$0.80 | -$0.09 | |
| Weighted Average Basic Share | $90.8M | $98.5M | $108.9M | $138.1M | $152.4M | |
| Weighted Average Diluted Share | $90.8M | $98.5M | $108.9M | $138.1M | $152.4M | |
| EBITDA | -$222.5M | -$215.3M | -$176.7M | -$103.8M | -$5.1M | |
| EBIT | -$225.4M | -$218.3M | -$179.6M | -$106.7M | -$7.5M | |
| Revenue (Reported) | $88.6M | $86.3M | $107.7M | $127M | $144.3M | |
| Operating Income (Reported) | -$228.2M | -$217.8M | -$174.7M | -$110.6M | -$11.5M | |
| Operating Income (Adjusted) | -$225.4M | -$218.3M | -$179.6M | -$106.7M | -$7.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $20M | $23.5M | $29.6M | $34.7M | $38.9M | |
| Revenue Growth (YoY) | -21.19% | 17.18% | 26.25% | 17.07% | 12.21% | |
| Cost of Revenues | $9.2M | $11.4M | $16.9M | $8.4M | $8.5M | |
| Gross Profit | $10.8M | $12.1M | $12.8M | $26.2M | $30.4M | |
| Gross Profit Margin | 54.01% | 51.59% | 43.09% | 75.65% | 78.26% | |
| R&D Expenses | $38.1M | $42.1M | $8.8M | $4.6M | $2.3M | |
| Selling, General & Admin | $24.8M | $33M | $37M | $26.4M | $25M | |
| Other Inc / (Exp) | -$500K | -$965K | $295K | $1.6M | -$519K | |
| Operating Expenses | $62.9M | $75M | $45.8M | $31M | $27.3M | |
| Operating Income | -$52.1M | -$62.9M | -$33.1M | -$4.8M | $3.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$52.6M | -$63.9M | -$32.8M | -$3.2M | $2.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$52.6M | -$63.9M | -$32.8M | -$3.2M | $2.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$52.6M | -$63.9M | -$32.8M | -$3.2M | $2.6M | |
| Basic EPS (Cont. Ops) | -$0.58 | -$0.63 | -$0.27 | -$0.02 | $0.02 | |
| Diluted EPS (Cont. Ops) | -$0.58 | -$0.63 | -$0.27 | -$0.02 | $0.02 | |
| Weighted Average Basic Share | $91.4M | $102.1M | $119.2M | $151.2M | $153.5M | |
| Weighted Average Diluted Share | $91.4M | $102.1M | $119.2M | $151.2M | $153.5M | |
| EBITDA | -$51.4M | -$62.2M | -$32.3M | -$4.1M | $3.7M | |
| EBIT | -$52.1M | -$62.9M | -$33.1M | -$4.8M | $3.2M | |
| Revenue (Reported) | $20M | $23.5M | $29.6M | $34.7M | $38.9M | |
| Operating Income (Reported) | -$52.1M | -$62.9M | -$33.1M | -$4.8M | $3.2M | |
| Operating Income (Adjusted) | -$52.1M | -$62.9M | -$33.1M | -$4.8M | $3.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $83.3M | $89.8M | $113.8M | $132.1M | $148.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $34.8M | $48.2M | $60.4M | $56.7M | $38.7M | |
| Gross Profit | $48.5M | $41.6M | $53.5M | $75.4M | $109.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $175.8M | $134.8M | $49.5M | $34.9M | $14.4M | |
| Selling, General & Admin | $100.3M | $135.5M | $148.8M | $122.8M | $99.1M | |
| Other Inc / (Exp) | -$2.5M | -$1.3M | -$5.3M | $1.9M | -$1.7M | |
| Operating Expenses | $276M | $270.3M | $198.3M | $157.8M | $113.4M | |
| Operating Income | -$227.5M | -$228.6M | -$144.8M | -$82.4M | -$3.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$228.3M | -$232M | -$150.9M | -$81M | -$7.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$228.3M | -$232M | -$150.9M | -$81M | -$7.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$228.3M | -$232M | -$150.9M | -$81M | -$7.8M | |
| Basic EPS (Cont. Ops) | -$2.51 | -$2.30 | -$1.37 | -$0.59 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$2.51 | -$2.30 | -$1.37 | -$0.59 | -$0.05 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$221.8M | -$226.1M | -$146.8M | -$75.6M | $2.8M | |
| EBIT | -$224.8M | -$229.1M | -$149.7M | -$78.4M | $404K | |
| Revenue (Reported) | $83.3M | $89.8M | $113.8M | $132.1M | $148.5M | |
| Operating Income (Reported) | -$227.5M | -$228.6M | -$144.8M | -$82.4M | -$3.6M | |
| Operating Income (Adjusted) | -$224.8M | -$229.1M | -$149.7M | -$78.4M | $404K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $20M | $23.5M | $29.6M | $34.7M | $38.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.2M | $11.4M | $16.9M | $8.4M | $8.5M | |
| Gross Profit | $10.8M | $12.1M | $12.8M | $26.2M | $30.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $38.1M | $42.1M | $8.8M | $4.6M | $2.3M | |
| Selling, General & Admin | $24.8M | $33M | $37M | $26.4M | $25M | |
| Other Inc / (Exp) | -$500K | -$965K | $295K | $1.6M | -$519K | |
| Operating Expenses | $62.9M | $75M | $45.8M | $31M | $27.3M | |
| Operating Income | -$52.1M | -$62.9M | -$33.1M | -$4.8M | $3.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$52.6M | -$63.9M | -$32.8M | -$3.2M | $2.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$52.6M | -$63.9M | -$32.8M | -$3.2M | $2.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$52.6M | -$63.9M | -$32.8M | -$3.2M | $2.6M | |
| Basic EPS (Cont. Ops) | -$0.58 | -$0.63 | -$0.27 | -$0.02 | $0.02 | |
| Diluted EPS (Cont. Ops) | -$0.58 | -$0.63 | -$0.27 | -$0.02 | $0.02 | |
| Weighted Average Basic Share | $91.4M | $102.1M | $119.2M | $151.2M | $153.5M | |
| Weighted Average Diluted Share | $91.4M | $102.1M | $119.2M | $151.2M | $153.5M | |
| EBITDA | -$51.4M | -$62.2M | -$32.3M | -$4.1M | $3.7M | |
| EBIT | -$52.1M | -$62.9M | -$33.1M | -$4.8M | $3.2M | |
| Revenue (Reported) | $20M | $23.5M | $29.6M | $34.7M | $38.9M | |
| Operating Income (Reported) | -$52.1M | -$62.9M | -$33.1M | -$4.8M | $3.2M | |
| Operating Income (Adjusted) | -$52.1M | -$62.9M | -$33.1M | -$4.8M | $3.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $105.1M | $90.5M | $15.4M | $28.7M | $25.8M | |
| Short Term Investments | $103.4M | $67M | $69.5M | $51.7M | $33.5M | |
| Accounts Receivable, Net | $41.9M | $35.5M | $52M | $60.1M | $78.9M | |
| Inventory | $41.9M | $48.4M | $54.6M | $42.1M | $53.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $22M | $13M | $14M | $6.1M | $17.7M | |
| Total Current Assets | $314.2M | $254.4M | $205.4M | $188.8M | $209M | |
| Property Plant And Equipment | $39M | $33.6M | $29.8M | $25.6M | $17.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $346K | $17.7M | $15.7M | $8.1M | $6.5M | |
| Total Assets | $353.6M | $305.7M | $251M | $222.5M | $233.1M | |
| Accounts Payable | $629K | $3.9M | $3.6M | $3.8M | $11.7M | |
| Accrued Expenses | $79.9M | $51.3M | $64.8M | $65M | $68.7M | |
| Current Portion Of Long-Term Debt | $7.1M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3M | $2.4M | $2.7M | $3.1M | $3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $102.5M | $71.1M | $82.4M | $79.7M | $91.5M | |
| Long-Term Debt | -- | $149.1M | $149.3M | $173.8M | $174.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $117.1M | $228.1M | $237.4M | $256.5M | $266.8M | |
| Common Stock | $913K | $1M | $1.2M | $1.5M | $1.5M | |
| Other Common Equity Adj | $257K | -$6K | -$19K | $13K | $13K | |
| Common Equity | $236.5M | $77.6M | $13.6M | -$34M | -$33.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $236.5M | $77.6M | $13.6M | -$34M | -$33.7M | |
| Total Liabilities and Equity | $353.6M | $305.7M | $251M | $222.5M | $233.1M | |
| Cash and Short Terms | $208.5M | $157.6M | $84.9M | $80.4M | $59.3M | |
| Total Debt | $7.1M | $149.1M | $149.3M | $173.8M | $174.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $59.7M | $56.9M | $27.1M | $20.5M | $19.3M | |
| Short Term Investments | $106.7M | $55M | $32.9M | $51.1M | $31.4M | |
| Accounts Receivable, Net | $38.5M | $41.1M | $51.4M | $65.3M | $78.7M | |
| Inventory | $42.6M | $56.5M | $52.1M | $42.5M | $56.9M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $24.7M | $13.1M | $14.6M | $6.6M | $26.5M | |
| Total Current Assets | $272.3M | $222.6M | $178.2M | $185.9M | $212.8M | |
| Property Plant And Equipment | $38.3M | $33.2M | $28.6M | $24.1M | $16.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $346K | $18M | $14.1M | $7.9M | $6.3M | |
| Total Assets | $310.9M | $273.7M | $220.9M | $217.9M | $235.8M | |
| Accounts Payable | $1.7M | $8.2M | $4.1M | $837K | $12.3M | |
| Accrued Expenses | $88.6M | $82.3M | $71.1M | $71.4M | $73.9M | |
| Current Portion Of Long-Term Debt | $7.6M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.1M | $2.5M | $2.8M | $3.1M | $2.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $100.9M | $93M | $77.9M | $75.4M | $88.6M | |
| Long-Term Debt | -- | $149.1M | $149.3M | $174M | $175M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $114.7M | $249.8M | $232.3M | $251.7M | $264.2M | |
| Common Stock | $914K | $1M | $1.2M | $1.5M | $1.5M | |
| Other Common Equity Adj | $121K | -$8K | $9K | -$6K | $1K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $196.2M | $24M | -$11.4M | -$33.8M | -$28.5M | |
| Total Liabilities and Equity | $310.9M | $273.7M | $220.9M | $217.9M | $235.8M | |
| Cash and Short Terms | $166.5M | $111.9M | $60M | $71.5M | $50.7M | |
| Total Debt | $7.6M | $149.1M | $149.3M | $174M | $175M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$227.3M | -$220.7M | -$182M | -$110.6M | -$13.6M | |
| Depreciation & Amoritzation | $2.8M | $3M | $2.9M | $2.9M | $2.5M | |
| Stock-Based Compensation | $50.2M | $46.9M | $43M | $32.9M | $13M | |
| Change in Accounts Receivable | -$2M | $6.4M | -$16.6M | -$8.1M | -$18.7M | |
| Change in Inventories | -$16.9M | -$6.5M | -$6.2M | $12.5M | -$11.1M | |
| Cash From Operations | -$184.8M | -$203.4M | -$146.9M | -$58.8M | -$22.5M | |
| Capital Expenditures | $6.8M | $3M | $1.8M | $1.5M | $1.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $209M | $32.7M | -$3.3M | $18M | $18.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $26K | $149M | -- | $24.4M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $9.1M | $156M | $75.1M | $54.1M | $940K | |
| Beginning Cash (CF) | $71.9M | $105.1M | $90.5M | $15.4M | $28.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $33.2M | -$14.6M | -$75.2M | $13.3M | -$2.9M | |
| Ending Cash (CF) | $105.1M | $90.5M | $15.4M | $28.7M | $25.8M | |
| Levered Free Cash Flow | -$191.6M | -$206.4M | -$148.7M | -$60.3M | -$24.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$52.6M | -$63.9M | -$32.8M | -$3.2M | $2.6M | |
| Depreciation & Amoritzation | $739K | $721K | $718K | $689K | $551K | |
| Stock-Based Compensation | $11.5M | $10.9M | $7.9M | $3.4M | $2.5M | |
| Change in Accounts Receivable | $3.3M | -$5.6M | $601K | -$5.2M | $145K | |
| Change in Inventories | -$724K | -$8.1M | $2.5M | -$363K | -$3.8M | |
| Cash From Operations | -$41.9M | -$43.9M | -$24.9M | -$9.5M | -$8.9M | |
| Capital Expenditures | $786K | $1M | $224K | -- | $109K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.3M | $10.9M | $36.8M | $1.3M | $2.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $883K | -$637K | -$208K | $11K | $64K | |
| Beginning Cash (CF) | $105.1M | $90.5M | $15.4M | $28.7M | $25.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$45.4M | -$33.6M | $11.7M | -$8.2M | -$6.5M | |
| Ending Cash (CF) | $59.7M | $56.9M | $27.1M | $20.5M | $19.3M | |
| Levered Free Cash Flow | -$42.7M | -$45M | -$25.1M | -$9.5M | -$9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$228.3M | -$232M | -$150.9M | -$81M | -$7.8M | |
| Depreciation & Amoritzation | $3M | $3M | $2.9M | $2.9M | $2.4M | |
| Stock-Based Compensation | $49.7M | $46.3M | $40M | $28.3M | $12.1M | |
| Change in Accounts Receivable | -$3.7M | -$2.6M | -$10.3M | -$13.9M | -$13.4M | |
| Change in Inventories | -$7.8M | -$13.8M | $4.4M | $9.6M | -$14.5M | |
| Cash From Operations | -$193.8M | -$205.4M | -$127.9M | -$43.4M | -$21.9M | |
| Capital Expenditures | $4.7M | $3.3M | $1M | $1.3M | $1.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $140.8M | $48M | $22.6M | -$17.6M | $19.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $9.5M | $154.5M | $75.5M | $54.3M | $993K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$43.5M | -$2.8M | -$29.8M | -$6.6M | -$1.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$198.5M | -$208.6M | -$128.9M | -$44.7M | -$23.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$52.6M | -$63.9M | -$32.8M | -$3.2M | $2.6M | |
| Depreciation & Amoritzation | $739K | $721K | $718K | $689K | $551K | |
| Stock-Based Compensation | $11.5M | $10.9M | $7.9M | $3.4M | $2.5M | |
| Change in Accounts Receivable | $3.3M | -$5.6M | $601K | -$5.2M | $145K | |
| Change in Inventories | -$724K | -$8.1M | $2.5M | -$363K | -$3.8M | |
| Cash From Operations | -$41.9M | -$43.9M | -$24.9M | -$9.5M | -$8.9M | |
| Capital Expenditures | $786K | $1M | $224K | -- | $109K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.3M | $10.9M | $36.8M | $1.3M | $2.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $883K | -$637K | -$208K | $11K | $64K | |
| Beginning Cash (CF) | $105.1M | $90.5M | $15.4M | $28.7M | $25.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$45.4M | -$33.6M | $11.7M | -$8.2M | -$6.5M | |
| Ending Cash (CF) | $59.7M | $56.9M | $27.1M | $20.5M | $19.3M | |
| Levered Free Cash Flow | -$42.7M | -$45M | -$25.1M | -$9.5M | -$9M | |
Get HRTX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HRTX
Sector
P/E ratio
--
24.07x
PEG ratio
--
0.00x
P/B ratio
--
1.81x
Price / LTM sales
2.06x
1.67x
Growth Metrics
HRTX
Sector
Revenue growth
12.21%
4.06%
Earnings growth
--
7.49%
Revenue (5-year growth)
-0.23%
8.01%
Earnings forecast
-$0.01
-$0.20
Profitability
HRTX
Sector
Profitability FY 2024
$105.6M
$47.5M
Return on invested capital
-5.57%
-16.26%
Return on assets
-3.46%
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
5
Balance Sheet
HRTX
Sector
Total cash
$50.7M
$35.7M
Short term investments
$33.5M
$29.7M
Total assets
$233.1M
$106.9M
Long term debt
$175M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
